Types of Studies
To be considered for NIHR Clinical Research Network Support within the Diabetes Portfolio a study must:
- Be a ‘research study’ which is defined by the Department of Health as “the attempt to derive generalisable (i.e. of value to others in a similar situation) new knowledge by addressing clearly defined questions with systematic and rigorous methods"
- Have full research funding. This is the primary determinant of eligibility for consideration for NIHR CRN support. Study Funders (companies, institutions or organisations) determine the eligibility ‘route’ of a study for consideration for NIHR CRN support.
A study which has some of its funding provided by the NIHR, other areas of Government or NIHR non-commercial Partners (and fulfils the criteria above) is automatically eligible for consideration for NIHR CRN support.
NIHR non-commercial Partners are organisations that "Award research funds as a result of open competition in England with high quality peer review." Definitions of open competition and high quality peer review can be found at www.crncc.nihr.ac.uk/portfolio_eligibility
In addition the organisation must fund research that is of clear value to the NHS and take appropriate account of the priorities, needs and realities of the NHS in making decisions about the research that they fund.
- An investigator initiated trial (i.e. commercial collaborative research) and a study which is funded by an overseas Government or an overseas charity, is potentially eligible for consideration for NIHR CRN support.
- A potentially eligible study must undergo a formal adoption process to be considered for NIHR CRN support.
- The non-commercial adoption process involves review by subject specific experts against specific criteria focused on:
- Quality (as evidence by peer review)
- Feasibility of the study to run in the UK
- Benefit to the NHS
- Funding open to all qualified researchers in England
For more information on the portfolio eligibility criteria please contact the Diabetes Research Network Coordinating Centre using the email form provided on our Contact Us page.